by cbccadmin | Feb 1, 2023 | Uncategorized
We are excited to attend DCAT Week, a premier event held annually in New York City for companies engaged in the Global Bio/Pharmaceutical Manufacturing Value Chain. Date: 20 – 23 March, 2023 Location: New York City For more information about this conference,...
by cbccadmin | Jan 19, 2023 | Uncategorized
CBCC Global Research is proud to announce the successful completion of USFDA inspection for Psychiatry PKBE trial with “ZERO 483” at Junagadh site. We congratulate our dedicated team working on this important trial!...
by cbccadmin | Jan 4, 2023 | Uncategorized
Manoj Vyas (CEO – CBCC Global Research) will be attending The 41st Annual J.P.Morgan Healthcare Conference, the largest and most informative healthcare investment symposium in the industry, during 9 – 12 January 2023, at San Francisco, CA. For more information about...
by cbccadmin | Dec 1, 2022 | Uncategorized
Join CBCC Global Research team members Udayan Vyas (AGM – Business Development) and Ajit Upadhyaya (AGM – Business Development) for 17th Biosimilars Congregation 2022 on 13th December, 2022 at Hotel Kohinoor Continental, Mumbai, India. About CBCC Global Research...
by cbccadmin | Nov 8, 2022 | Uncategorized
CBCC Global Research looks forward to working with MediPrint Ophthalmics on this important study to help move #ophthalmic drug delivery forward. The #drugeluting contact lens platform is an important option for millions of patients. We also congratulate MediPrint on...
by cbccadmin | Nov 4, 2022 | Uncategorized
Keen on learning best practices, seize opportunities, and overcome challenges linked to IND submissions for products which fall under the 505(b)(2) regulatory pathway? Access to the latest webinar on: Overview of the 505(b)(2) regulatory pathway for NDA Webinar Link:...
bd@cbcc.global